Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Tenapanor

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Optimize Study Post-Hoc Analysis Supporting XPHOZAH at NKF Meetings
    Optimize Study Post-Hoc Analysis Supporting XPHOZAH at NKF Meetings

    10 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/10/3059694/0/en/Post-Hoc-Analysis-of-the-OPTIMIZE-Study-Supporting-XPHOZAH-tenapanor-to-be-Presented-at-the-National-Kidney-Foundation-Spring-Clinical-Meetings.html

    GLOBENEWSWIRE
    10 Apr 2025
    Share Share
    Ardelyx Shares Post-Hoc Analysis of OPTIMIZE Study at NKF Spring
    Ardelyx Shares Post-Hoc Analysis of OPTIMIZE Study at NKF Spring

    31 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/31/3052751/0/en/Ardelyx-to-Share-a-Post-Hoc-Analysis-of-the-OPTIMIZE-Study-Supporting-XPHOZAH-tenapanor-at-the-National-Kidney-Foundation-Spring-Clinical-Meetings.html

    GLOBENEWSWIRE
    31 Mar 2025
    Share Share
    Tenapanor Approved in China for Hyperphosphatemia
    Tenapanor Approved in China for Hyperphosphatemia

    26 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/26/3032784/0/en/Tenapanor-Approved-in-China-for-Hyperphosphatemia.html

    GLOBENEWSWIRE
    26 Feb 2025
    Share Share
    Ardelyx Shares Data On XPHOZAH® At Kidney Week
    Ardelyx Shares Data On XPHOZAH® At Kidney Week

    24 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/10/24/2969087/0/en/Ardelyx-Shares-Additional-Data-Supporting-First-In-Class-XPHOZAH-tenapanor-at-the-American-Society-of-Nephrology-s-Kidney-Week.html

    GLOBENEWSWIRE
    24 Oct 2024
    Share Share
    Ardelyx Presents Data Supporting Xphozah In Chronic Kidney Disease
    Ardelyx Presents Data Supporting Xphozah In Chronic Kidney Disease

    15 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/15/2963102/0/en/Ardelyx-to-Present-Additional-Data-Supporting-First-In-Class-XPHOZAH-tenapanor-for-Adults-with-Chronic-Kidney-Disease-on-Dialysis-at-the-American-Society-of-Nephrology-s-Kidney-Wee.html

    GLOBENEWSWIRE
    15 Oct 2024
    Share Share
    Ardelyx To Participate At Cantor Global Healthcare Conference
    Ardelyx To Participate At Cantor Global Healthcare Conference

    05 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/05/2941309/0/en/Ardelyx-to-Participate-at-the-2024-Cantor-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    05 Sep 2024
    Share Share